HM02329 | FEZ2 | muscle | MESH:D008113 | Liver Neoplasms | |
HM02329 | FEZ2 | muscle | MESH:D008113 | Liver Neoplasms | |
HM02329 | FEZ2 | muscle | MESH:D000230 | Adenocarcinoma | |
HM02329 | FEZ2 | muscle | MESH:D000230 | Adenocarcinoma | uterus |
HM02329 | FEZ2 | muscle | MESH:D000230 | Adenocarcinoma | |
HM02329 | FEZ2 | muscle | MESH:D000230 | Adenocarcinoma | |
HM02329 | FEZ2 | muscle | MESH:D000230 | Adenocarcinoma | uterus |
HM02329 | FEZ2 | muscle | MESH:D000230 | Adenocarcinoma | thyroid |
HM02329 | FEZ2 | muscle | MESH:D000230 | Adenocarcinoma | skin |
HM02329 | FEZ2 | muscle | MESH:D000230 | Adenocarcinoma | parathyroid gland |
HM02329 | FEZ2 | muscle | MESH:D000230 | Adenocarcinoma | liver |
HM02329 | FEZ2 | muscle | MESH:D000230 | Adenocarcinoma | kidney |
HM02329 | FEZ2 | muscle | MESH:D000230 | Adenocarcinoma | eye |
HM02329 | FEZ2 | muscle | MESH:D000230 | Adenocarcinoma | adrenal gland |
HM02329 | FEZ2 | muscle | MESH:D009362 | Neoplasm Metastasis | |
HM02329 | FEZ2 | muscle | MESH:D002294 | Carcinoma, Squamous Cell | lung |
HM02329 | FEZ2 | muscle | MESH:D002294 | Carcinoma, Squamous Cell | liver |
HM02329 | FEZ2 | muscle | MESH:D002294 | Carcinoma, Squamous Cell | larynx |
HM02329 | FEZ2 | muscle | MESH:D002294 | Carcinoma, Squamous Cell | kidney |
HM02329 | FEZ2 | muscle | MESH:D002294 | Carcinoma, Squamous Cell | eye |
HM02329 | FEZ2 | muscle | MESH:D006330 | Heart Defects, Congenital | |
HM02329 | FEZ2 | muscle | MESH:D004938 | Esophageal Neoplasms | |
HM02329 | FEZ2 | muscle | MESH:D002277 | Carcinoma | |
HM02329 | FEZ2 | muscle | MESH:D006528 | Carcinoma, Hepatocellular | liver |
HM02329 | FEZ2 | muscle | MESH:D017114 | Liver Failure, Acute | |
HM02329 | FEZ2 | muscle | MESH:D008114 | Liver Neoplasms, Experimental | |
HM02329 | FEZ2 | muscle | MESH:D013274 | Stomach Neoplasms | |
HM02329 | FEZ2 | muscle | MESH:D000236 | Adenoma | pancreas |
HM02329 | FEZ2 | muscle | MESH:D000236 | Adenoma | liver |
HM02329 | FEZ2 | muscle | MESH:D000236 | Adenoma | kidney |
HM02329 | FEZ2 | muscle | MESH:D000236 | Adenoma | |
HM02329 | FEZ2 | muscle | MESH:D000236 | Adenoma | |
HM02329 | FEZ2 | muscle | MESH:D000236 | Adenoma | |
HM02329 | FEZ2 | muscle | MESH:D000236 | Adenoma | |
HM02329 | FEZ2 | muscle | MESH:D018248 | Adenoma, Liver Cell | |
HM02329 | FEZ2 | muscle | MESH:D008107 | Liver Diseases | skin |
HM02329 | FEZ2 | muscle | MESH:D008107 | Liver Diseases | muscle |
HM02329 | FEZ2 | muscle | MESH:D008107 | Liver Diseases | lung |
HM02329 | FEZ2 | muscle | MESH:D008107 | Liver Diseases | liver |
HM02329 | FEZ2 | muscle | MESH:D008175 | Lung Neoplasms | lung |
HM02329 | FEZ2 | muscle | MESH:D056486 | Drug-Induced Liver Injury | |
HM02329 | FEZ2 | muscle | MESH:D011230 | Precancerous Conditions | |
HM02329 | FEZ2 | muscle | MESH:D008106 | Liver Cirrhosis, Experimental | |
HM02329 | FEZ2 | muscle | MESH:D013158 | Splenic Diseases | spleen |